Capital Flow Monitor · Sponsors · CIK 2001012
Atommap Corp
1059 3RD AVENUE, NEW YORK, NY, 10065 · 9179688176
Biotechnology · Corporation· inc. DELAWARE true 2023
Fit score
—
Offering
$59.6M
Sold
$31.1M
% sold
52.2%
Investors
29
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-03-20 | D ·current | 506(b) | $59.6M | $31.1M | 52.2% | 29 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Huafeng Xu — Executive Officer / Director, New York, NY
-
Keith Loebner — Director, New York, NY
1 other raise
- Integrated Biosciences, Inc. $68.4M of $100.0M · 68.4%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.